The 2002 U.S. Public Health Service and Infectious Diseases Society of America guidelines provide evidence-based recommendations for preventing opportunistic infections among HIV-infected persons. This fourth edition addresses 19 specific opportunistic infections and includes major updates on discontinuing prophylaxis, hepatitis C screening, and drug interactions. The guidelines were authored by Jonathan E. Kaplan of the National Center for HIV/AIDS, Dermatology and STD.
Use Cases
- Training NLP models to extract clinical recommendations based on the structured guideline text.
- Analyzing temporal changes in public health policy based on the major updates listed from previous editions.
- Building a knowledge base for HIV care based on the 19 addressed opportunistic infections and prophylaxis strategies.
Strengths
- Addresses 19 specific opportunistic infections or groups of infections.
- Provides evidence-based guidelines from two major U.S. health institutions.
- Includes major updates on five key clinical topics from the 1999 edition.
Limitations
- Row count and column-level documentation are absent; field semantics must be inferred after download.
- Last update date is unknown; freshness unverified.
Provenance
- Source
- U.S. Public Health Service and the Infectious Diseases Society of America
- Collection Method
- Clinical guideline development and synthesis of evidence.
- Time Range
- Guidelines published in 2002, with updates from 1995, 1997, and 1999.
- Geography
- Primarily United States.